Skip to content
healthcare.dev

Levetiracetam

NDC 51224-013, levetiracetam, injection, solution, concentrate, from TAGI Pharma, Inc..

Product NDC
51224-013
Status
Listed
Labeler
TAGI Pharma, Inc.
Dosage form
INJECTION, SOLUTION, CONCENTRATE
Route
INTRAVENOUS
Product type
HUMAN PRESCRIPTION DRUG
Marketing category
ANDA
Application
ANDA209781
DEA schedule
None
Request
curl https://api.healthcare.dev/v1/drugs/ndc/51224-013 \
  -H "Authorization: Bearer $HDEV_API_KEY"

Product

Active ingredients and packages

Active ingredients

  • LEVETIRACETAM100 mg/mL

Pharmacologic classes

Decreased Central Nervous System Disorganized Electrical Activity [PE]

Package NDCNDC-11Package

Linked data

RxNorm, label and prices

RxNorm concepts

RxNorm links no concept to this product's packages.

Related lookups

  • FDA label sections

    GET /v1/drugs/labels/72f7ddd9-1b2c-4e26-8060-20e10c1c5d1c

Use it

Look up 51224-013 from code or an agent

curl
curl https://api.healthcare.dev/v1/drugs/ndc/51224-013 \
  -H "Authorization: Bearer $HDEV_API_KEY"
MCP prompt
Using the healthcare.dev MCP server, look up NDC 51224-013. Tell me the product, its labeler, dosage form and route, its packages, and the RxNorm concepts it maps to.

Source: FDA, release 2026-10-23. Public domain. Reference data, not medical advice.